Ask The Experts: Hybrid LBA/LC–MS
Historically, LBA and LC–MS have been acclaimed as gold-standard technologies in large molecule and small molecule quantification respectively. However, advances in the field have…
Ask The Experts: The Impact Of COVID-19 On The Lab
In this Ask the Experts feature, our experts explain how their laboratories have been affected by the COVID-19 pandemic, explore whether their institution will…
QPS Taiwan: New Facility Expansion And The Challenges Of Pharmacology Drug-Related Projects
In this interview, Charlene Chen (QPS; Taipei, Taiwan) summarizes what QPS hopes to achieve with their new Center of Toxicology and Preclinical Sciences, which…
Recent Developments In Oligonucleotide Analysis
In this Bioanalysis Zone interview, Zamas Lam (QPS; DE, USA) discusses various methods that can be used to quantify oligonucleotide drugs. Zamas also explains…
How Are Pharmacology Disease State Models Used For Drug Development?
In this interview with Meiling Hou (QPS; Taipei, Taiwan), we explore pharmacology studies and their role in drug development. Meiling explores the challenges of…
Innovative New Leukopak Facility At QPS
In this interview with Polung Yang (QPS; Taipei, Taiwan), we explore the evolution and innovation of automated procedures in primary cell procurement and delivery….
Electrophoretic Mobility Shift Assay (EMSA) As An Alternative Approach For The Estimation Of Plasma Protein Binding Of Oligonucleotides
In this interview, Wenbin Liu (QPS; DE, USA) walks us through the role of plasma protein binding (PPB) studies in drug development, focusing on…
RadioADME Studies Of Oligonucleotides
In this expert interview, we speak with Deborah Watson, Group Leader of DMPK (in vivo) at QPS (DE, USA), to explore the crucial role…
Brexit Or Not, The Drug Research And Development Landscape Has Changed
Brexit or no Brexit? The question that has been weighing on the UK for the past 3 years will soon have an answer (hopefully)….